Results 101 to 110 of about 6,612,439 (184)

Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay

AAPS Journal, 2015
Yan G. Ni, Xiling Yuan, J. Newitt, J. Peterson, C. Gleason, Jonathan Haulenbeek, Rasa Santockyte, V. Lafont, F. Marsilio, Robert J. Neely, Binodh S Desilva, S. Piccoli   +11 more
semanticscholar   +1 more source

Philippe Gardy, Paysages du poème, Six poètes d’oc entre xxe et xxie siècle. Léon Cordes, Robert Lafont, Bernard Lesfargues, Georges Reboul, Max Rouquette et Jean-Calendal Vianès.

Revue des Langues Romanes, 2015
Claire Torreilles
doaj   +1 more source

Improved Survival in Rhesus Macaques Immunized with Modified Vaccinia Virus Ankara Recombinants Expressing Simian Immunodeficiency Virus Envelope Correlates with Reduction in Memory CD4+ T-Cell Loss and Higher Titers of Neutralizing Antibody

Journal of Virology, 2009
I. Ourmanov, T. Kuwata, Robert M. Goeken, S. Goldstein, R. Iyengar, A. Buckler-White, B. Lafont, V. Hirsch   +7 more
semanticscholar   +1 more source

Una carta de Robert Lafont a Antoni Cayrol (Jordi Pere Cerdà), de 1959 : mirall d'un combat per a l'ensenyament i altres engatjaments per a la llengua del poble

Lengas, 2008
Lluc Bonet
doaj   +1 more source

Early Short-Term Antiretroviral Therapy Is Associated with a Reduced Prevalence of CD8+FoxP3+ T Cells in Simian Immunodeficiency Virus-Infected Controller Rhesus Macaques

AIDS Research and Human Retroviruses, 2011
Jeffy George, E. Cofano, Elizabeth Lybarger, M. Louder, B. Lafont, J. Mascola, M. Robert-Guroff, J. Mattapallil   +7 more
semanticscholar   +1 more source

Carta manuscrita de Bernard Lesfargues a Robert Lafont

, 1966
Lesfargues es disculpa davant Robert Lafont per no haver-lo pogut acollir com ell volia, degut a que va haver de preparar una conferència a última ...
Lesfargues, Bernard, Lafont, Robert
core  

Clonal expansion and compartmentalized maintenance of rhesus macaque NK cell subsets. [PDF]

Sci Immunol, 2018
Wu C, Espinoza DA, Koelle SJ, Yang D, Truitt L, Schlums H, Lafont BA, Davidson-Moncada JK, Lu R, Kaur A, Hammer Q, Li B, Panch S, Allan DA, Donahue RE, Childs RW, Romagnani C, Bryceson YT, Dunbar CE.   +18 more
europepmc   +1 more source

Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents. [PDF]

Commun Biol, 2022
Zarkoob H, Allué-Guardia A, Chen YC, Garcia-Vilanova A, Jung O, Coon S, Song MJ, Park JG, Oladunni F, Miller J, Tung YT, Kosik I, Schultz D, Iben J, Li T, Fu J, Porter FD, Yewdell J, Martinez-Sobrido L, Cherry S, Torrelles JB, Ferrer M, Lee EM.   +22 more
europepmc   +1 more source

Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect. [PDF]

J Exp Med
Rhodehouse K, Zitzmann C, Ravi M, Armstrong C, Moskovljevic M, Moore HP, Schill C, Fray EJ, Kumar MR, Penney T, Krzykwa C, Stauss MR, Wiseman RW, O'Connor DH, Fennessey CM, Keele BF, Lifson JD, Ribeiro RM, Perelson AS, Hoxie JA, Maness NJ, Siliciano JD, Siliciano RF.   +22 more
europepmc   +1 more source

Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases. [PDF]

Cell Death Dis, 2022
Risso V, Lafont E, Le Gallo M.
europepmc   +1 more source